LOS ANGELES--(BUSINESS WIRE)--Goldberg Law PC, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Envision Healthcare Corporation (“Envision” or the “Company”) (NYSE: EVHC).
If you purchased or otherwise acquired Envision shares, and would like more information about the investigation, we encourage you to contact Michael Goldberg or Brian Schall, of Goldberg Law PC, 1999 Avenue of the Stars, Suite 1100, Los Angeles, CA 90067, at 800-977-7401, to discuss your rights without cost to you.
The investigation focuses on whether Envision and certain of its officers and/or directors violated federal securities laws. On July 24, 2017, The New York Times reported that physicians associated with the Company’s subsidiary, EmCare Holdings Inc., were disproportionately likely to engage in practices such as surprise billing in which patients who go to in-network hospitals are treated by out-of-network doctors, who then bill them at higher rates. Following this news, Envision’s stock price dropped.
If you have any questions concerning your legal rights, please immediately contact Goldberg Law PC at 800-977-7401, or visit our website at http://www.Goldberglawpc.com, or email us at firstname.lastname@example.org.
Goldberg Law PC represents investors around the world, and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.